Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Fervo Energy Publicly Announces Filing of Registration Statement for Proposed Initial Public Offering
-
Rally House Expands Triangle Presence with Cary Location
-
Mannatech Reports Financial Results for Fourth Quarter and Year Ended 2025
-
Itafos Announces Release Date for Q1 2026 Results and Business Update Webcast
-
CVB Financial Corp. Announces Completion of Merger with Heritage Commerce Corp
-
Arbe Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
-
Rocket Doctor Amends 45 Degree Agreement
-
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
-
Result of Voting for Directors at Annual Shareholders’ Meeting
-
Sow Good Inc. Announces Reverse Stock Split
-
Notice of 2026 First Quarter Results Conference Call and Webcast for Investors and Analysts and Annual Meeting of Shareholders
-
LGI Homes Expands in the Salt Lake City Market with Grand Opening of Desert Edge
-
HYTN Introduces HARd Remediation to GMP Processing Services, Releases Product in Germany
-
Callan JMB Issues Statement on Recently Filed Lawsuit by Eddie Patent Holdings LLC
-
Boundless Bio Presents Preclinical Breast Cancer Data from its Oral Kinesin Degrader Program at 2026 AACR Annual Meeting
-
Japan Smaller Capitalization Fund, Inc. Announces Board Determination to Proceed with Conditional Tender Offer
-
Celularity Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing
-
Sysco Declares Increase to Quarterly Dividend Payment
-
Tree Island Steel Provides Update on Annual General Meeting of Shareholders
-
Lincoln Educational Services Corporation Schedules First Quarter 2026 Earnings Release And Conference Call
-
BGIN BLOCKCHAIN LIMITED Schedules the Fiscal Year 2025 Earnings and Conference Call on April 24, 2026
-
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Quantify Funds to Close STKd 100% NVDA & 100% AMD ETF (LAYS)
-
Zacatecas Silver Announces Investor Relations Engagement
-
TTEC Schedules First Quarter 2026 Earnings Release and Webcast of Investor Conference Call
-
Sonoco To Report First Quarter 2026 Results
-
Vera Bradley Terminates Existing Shareholder Rights Plan
-
Theriva™ Biologics Announces Upcoming Presentation of Additional Data from the VIRAGE Phase 2b Clinical Trial of VCN-01 in Metastatic Pancreatic Cancer at AACR 2026 Annual Meeting
-
Talen Energy Announces Pricing of Senior Notes
-
ORIC® Pharmaceuticals Presents Preclinical Data to Support the Potential of Rinzimetostat Across Prostate Cancer and in Emerging Resistance Settings at the 2026 American Association for Cancer Resear
-
QuasarEdge Acquisition Corporation Announces Exercise of Over-Allotment Option
-
SEALSQ Announces Agenda of its 2026 Annual General Meeting of Shareholders
-
ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules
-
CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
4DMT Announces New Employment Inducement Grants
-
Pyxis Oncology to Present New Preclinical Data Showing Synergistic Anti-Tumor Activity in a HNSCC model with maMICVO in Combination with Anti-PD-1 at AACR 2026
-
VALUE LINE, INC. DIVIDEND HAS JUST BEEN RAISED FROM $1.30 TO $1.40 (ANNUALIZED) – ITS 12TH CONSECUTIVE INCREASE
-
Revolution Medicines Announces Closing of Concurrent Upsized Public Offerings with Aggregate Gross Proceeds of Approximately $2.2 Billion, Including Full Exercise of Underwriters’ Option to Purchase
-
Hingham Savings Reports First Quarter 2026 Results
-
New Era Energy & Digital Announces Appointment of Andy Casazza as Chief Corporate Officer
-
Cardiff Oncology Presents Preclinical Data on its PLK1 Inhibitor Onvansertib in Combination with a HER2-Targeted ADC at the 2026 AACR Annual Meeting
-
New Era Energy & Digital Announces Appointment of Andy Casazza as Chief Corporate Officer
-
Olema Oncology Announces Preclinical Data for Palazestrant and OP-3136 at the 2026 AACR Annual Meeting
-
Xilio Therapeutics Announces New Preclinical Data at AACR Annual Meeting for XTX601, a Masked T Cell Engager Targeting CLDN18.2
-
Adagene Presents Two Posters at AACR 2026 with New Data Highlighting Muzastotug’s Potential as a Backbone Combination Therapy for Multiple Tumor Types
-
Acrivon to Highlight Preclinical Data with Three Posters at AACR Demonstrating Strong ACR-368 and ACR-2316 Synergies with Immune Checkpoint Inhibitors and ADC Payloads, Revealing Broad Clinical Develo
-
Long Beach City College Wins Regional Construction Awards for Campus Upgrades
-
MLG Capital Recognized by National Multifamily Housing Council as a 2026 Top 50 Owner
-
NEXGEL Moves Forward Shareholder Update Call to Discuss Celularity Transaction on April 21st at 4:30 P.M. ET
-
Introspect Technology Adds New ATE-on-Bench Solution for LPDDR6, DDR6, and HBM Interfaces

